Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Simultaneous Vaccination With Zoster Vaccine Recombinant (RZV) and Quadrivalent Adjuvanted Inactivated Influenza Vaccine (aIIV4)

NCT05007041 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT05007041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05007041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Simultaneous Vaccination With Zoster Vaccine Recombinant (RZV) and Quadrivalent Adjuvanted Inactivated Influenza Vaccine (aIIV4)
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
September 21, 2021
Completion date
June 8, 2023
Enrollment
267 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event, injection site reaction, pain, quality of life